siRNA-induced suppression of FOXD2-AS1 (si-FOXD2-AS1) in human GBM cell lines, U251 and A172, is associated with hypermethylation of the MGMT promoter, resulting in decreased MGMT mRNA and protein levels. This evidence concerns the gene MGMT and glioblastoma.